EP006 — The Empty File (FDA Regulation, Part 1 of 2)

Why is one peptide in your morning smoothie and another one a grey-market gamble — when they’re both just peptides? Part one of our two-part regulatory deep dive traces how America decides what counts as a food, a supplement, or a drug, where peptides fall in that system, and what a major FDA advisory meeting can — and can’t — actually change. The molecules didn’t change. The rules did.

Link To Services

In this episode

A plain-English history of how the U.S. regulates what goes into your body — built to make sense of the FDA compounding meeting the whole peptide world was watching.
•The cold open: two peptides, one in a health-food aisle and one underground — and why the only real difference is the statute.
•A quick, non-boring history of drug regulation and the approval pathways peptides are forced to fit through.
•Peptides vs. vitamins: same “it’s just a supplement” instinct, wildly different rulebooks.
•What “Category 1” and “Category 2” actually mean — and what really stops your doctor from prescribing (often insurance, not law).
•Foreign research: why data from abroad frequently can’t cross the border, and why that’s structural rather than a conspiracy.
•“Phantom authority” — the fake citations and confidently-wrong sources that pollute this space, and how to spot them.
•What the advisory meeting is, isn’t, and could realistically change.

Part one sets the board. Part two picks up with what actually happened in the room.

Everything discussed on this show is for informational and educational purposes only, based on published research and community-reported experience. We are not doctors, and nothing here constitutes medical advice. Our goal is simple: to give you enough information to have a real, informed conversation with your own physician — one where you walk in knowing the right questions to ask. Please involve a qualified healthcare provider before making any changes to your health protocols. Don’t skip that step.